"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Iowa Heart Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 17 clinical trials were completed, i.e. on average, 106.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iowa Heart Center" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 10 trials, followed by "Abbott Medical Devices" with 5 trials sponsored, "Medtronic Cardiovascular" with 5 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored and "AUM Cardiovascular, Inc." with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iowa Heart Center" #1 collaborator was "Abbott" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "GE Healthcare" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Iowa Heart Center" are "Coronary Artery Disease" (10 trials), "Atherosclerosis" (5 trials), "Atrial Fibrillation" (5 trials), "Heart Failure" (5 trials) and "Myocardial Infarction" (3 trials). Many other conditions were trialed in "Iowa Heart Center" in a lesser frequency.

Most popular intervention types in "Iowa Heart Center" are "Device" (29 trials), "Drug" (16 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (3 trials), "Cardiac Resynchronization Therapy" (2 trials), "AGI-1067" (1 trials) and "ASP1128" (1 trials). Other intervention names were less common.

The vast majority of trials in "Iowa Heart Center" are 49 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Iowa Heart Center". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Iowa Heart Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Iowa Heart Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".

Iowa Heart Center has several departments that took part in Clinical trials: "Iowa Heart Center" - 68 trials, "Iowa Heart Center Research" - 2 trials, "Iowa City Heart Center" - 2 trials